http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113372405-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113372405-B |
| titleOfInvention | A kind of AKBA derivative and its preparation method and application |
| abstract | The present invention provides an AKBA derivative, which has the structure shown in formula I or formula II: Wherein, R 1 is selected from: -H or -Ac; R 2 is selected from: cycloalkyl, aryl, aryl substituted by at least one methyl group, C 1-7 linear or branched saturated alkyl, or n is an integer of 1-10. The AKBA derivative has stronger cytotoxicity than AKBA, and has lower toxicity to normal cells, and the AKBA derivative of the present invention has the potential to be used as an antitumor drug. |
| priorityDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.